Predictive value of serum CTRP9 and STIM1 for restenosis after cerebrovascular stent implantation and its relationship with vasoactive substances and inflammatory cytokines

Pan,Jiming; Cui,Xinguo; Wang,Guangbin; Xue,Kun; Hu,Jia; Zhou,Lu

doi:10.3892/etm.2020.9104

Predictive value of serum CTRP9 and STIM1 for restenosis after cerebrovascular stent implantation and its relationship with vasoactive substances and inflammatory cytokines

Authors:
- Jiming Pan
- Xinguo Cui
- Guangbin Wang
- Kun Xue
- Jia Hu
- Lu Zhou
View Affiliations

Affiliations: Department of Neurosurgery, Yantaishan Hospital, Yantai, Shandong 264000, P.R. China, Clinical Laboratory, Yantai Hospital of Traditional Chinese Medicine, Yantai, Shandong 264000, P.R. China
Published online on: August 6, 2020 https://doi.org/10.3892/etm.2020.9104
Pages: 2617-2622

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Predictive value of serum complement Clq tumor necrosis factor‑related protein 9 (CTRP9) and serum stromal interaction molecule 1 (STIM1) was investigated for restenosis after cerebrovascular stent implantation, as well as its relationship with vasoactive substances and inflammatory cytokines. In this prospective study, 128 patients with cerebral infarction treated with cerebrovascular stent implantation in Yantaishan Hospital were recruited. A total of 66 cases with restenosis after cerebrovascular stent implantation were included in group A, and 62 cases without stenosis were included in group B. Serum CTRP9 and STIM1 levels were measured by enzyme‑linked immunosorbent assay (ELISA). ROC curves of serum CTRP9 and STIM1 levels in patients with postoperative restenosis were drawn. The vasoactive substances nitric oxide (NO), tumor necrosis factor α (TNF‑α) and interleukin‑6 (IL‑6) were analyzed by ELISA. The correlation of serum CTRP9, STIM1 levels and NO, TNF‑α, IL‑6 were analyzed by Pearson correlation coefficient. Serum CTRP9 and NO levels in group A were significantly lower than those in group B. The levels of serum STIM1, TNF‑α and IL‑6 in group A were significantly higher than those in group B (P<0.001). The sensitivity and specificity of serum CTRP9 level in the diagnosis of restenosis after cerebrovascular stent implantation were, respectively, 59.68 and 75.76%. Those of serum STIM1 were, respectively, 87.10 and 46.97% and those of the combination of serum CTRP9 and STIM1 were 90.32 and 48.48%. Serum CTRP9 level was positively correlated with NO, and negatively correlated with TNF‑α and IL‑6. STIM1 was positively correlated with TNF‑α and IL‑6, and negatively correlated with NO (P<0.001). Serum CTRP9 level was significantly decreased in patients with restenosis after cerebrovascular stent implantation, while STIM1 level was significantly up‑regulated. Both were correlated with the change of NO, IL‑6 and TNF‑α levels, therefore they could be used as biological indicators for prediction of restenosis after cerebrovascular stent implantation.

View Figures

View References

1	Losito A, Pittavini L, Ferri C and De Angelis L: Kidney function and mortality in different cardiovascular diseases: Relationship with age, sex, diabetes and hypertension. J Nephrol. 24:322–328. 2011.PubMed/NCBI View Article : Google Scholar
2	Sairanen T, Strbian D, Ruuskanen R, Silvennoinen H, Salonen O and Lindsberg PJ: Symptomatic intracranial haemorrhage after thrombolysis with adjuvant anticoagulation in basilar artery occlusion. Eur J Neurol. 22:493–499. 2015.PubMed/NCBI View Article : Google Scholar
3	Mintz GS: Intravascular ultrasound and outcomes after drug- eluting stent implantation. Coron Artery Dis. 28:346–352. 2017.PubMed/NCBI View Article : Google Scholar
4	Guan CL, Shi GX, Li Q, Luo YM and Zeng YC: Prevention of complications following cerebrovascular stent implantation. J Clin Rehab Tissue Eng Res. 2 (Suppl)(S52)2010.
5	Dinesch V, Dinesch M and Buruian M: Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story. J Saudi Heart Assoc. 29:73–74. 2017.PubMed/NCBI View Article : Google Scholar
6	Ouchi N, Parker JL, Lugus JJ and Walsh K: Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 11:85–97. 2011.PubMed/NCBI View Article : Google Scholar
7	Lago F, Dieguez C, Gómez-Reino J and Gualillo O: Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol. 3:716–724. 2007.PubMed/NCBI View Article : Google Scholar
8	Smith CC and Yellon DM: Adipocytokines, cardiovascular pathophysiology and myocardial protection. Pharmacol Ther. 129:206–219. 2011.PubMed/NCBI View Article : Google Scholar
9	Schäffler A and Buechler C: CTRP family: Linking immunity to metabolism. Trends Endocrinol Metab. 23:194–204. 2012.PubMed/NCBI View Article : Google Scholar
10	Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, Ge G, Spooner E, Hug C, Gimeno R and Lodish HF: Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin. FASEB J. 23:241–258. 2009.PubMed/NCBI View Article : Google Scholar
11	Liou J, Fivaz M, Inoue T and Meyer T: Live-cell imaging reveals sequential oligomerization and local plasma membrane targeting of stromal interaction molecule 1 after Ca²⁺ store depletion. Proc Natl Acad Sci USA. 104:9301–9306. 2007.PubMed/NCBI View Article : Google Scholar
12	Estrada IA, Donthamsetty R, Debski P, Zhou MH, Zhang SL, Yuan JX, Han W and Makino A: STIM1 restores coronary endothelial function in type 1 diabetic mice. Circ Res. 111:1166–1175. 2012.PubMed/NCBI View Article : Google Scholar
13	Edgell RC, Zaidat OO, Gupta R, Abou-Chebl A, Linfante I, Xavier A, Nogueira R, Alshekhlee A, Kalia J, Etezadi V, et al: Multicenter study of safety in stenting for symptomatic vertebral artery origin stenosis: Results from the Society of Vascular and Interventional Neurology Research Consortium. J Neuroimaging. 23:170–174. 2013.PubMed/NCBI View Article : Google Scholar
14	Albuquerque FC, Fiorella D, Han P, Spetzler RF and Mc Dougall CG: A reappraisal of angioplasty and stenting for the treatment of vertebral origin stenosis. Neurosurgery. 53:607–616. 2003.PubMed/NCBI View Article : Google Scholar
15	Kang SJ, Mintz GS, Park DW, Lee SW, Kim YH, Lee CW, Han KH, Kim JJ, Park SW and Park SJ: Mechanisms of in-stent restenosis after drug-eluting stent implantation: Intravascular ultrasound analysis. Circ Cardiovasc Interv. 4:9–14. 2011.PubMed/NCBI View Article : Google Scholar
16	Virmani R, Liistro F, Stankovic G, Di Mario C, Montorfano M, Farb A, Kolodgie FD and Colombo A: Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation. 106:2649–2651. 2002.PubMed/NCBI View Article : Google Scholar
17	Peel SE, Liu B and Hall IP: A key role for STIM1 in store operated calcium channel activation in airway smooth muscle. Respir Res. 7(119)2006.PubMed/NCBI View Article : Google Scholar
18	Zheng Q, Yuan Y, Yi W, Lau WB, Wang Y, Wang X, Sun Y, Lopez BL, Christopher TA, Peterson JM, et al: Clq/TNF-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/e NOS/nitric oxide signaling pathway. Arterioscler Thromb Vasc Biol. 31:2616–2623. 2011.PubMed/NCBI View Article : Google Scholar
19	Takeuchi S, Wada K, Uozumi Y, Otani N, Osada H, Nagatani K and Mori K: Adiponectin receptor 1 expression is associated with carotid plaque stability. Neurol India. 61:249–253. 2013.PubMed/NCBI View Article : Google Scholar
20	Jing XD, Wei XM, Deng SB, Du JL, Liu YJ and She Q: The relationship between the high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P) and coronary in-stent restenosis. Clin Chim Acta. 15:248–252. 2015.PubMed/NCBI View Article : Google Scholar
21	Kambara T, Ohashi K, Shibata R, Ogura Y, Maruyama S, Enomoto T, Uemura Y, Shimizu Y, Yuasa D, Matsuo K, et al: CTRP9 protein protects against myocardial injury following ischemia-reperfusion through AMP-activated protein kinase (AMPK)-dependent mechanism. J Biol Chem. 287:18965–18973. 2012.PubMed/NCBI View Article : Google Scholar
22	Elnaggar MA, Seo SH, Gobaa S, Lim KS, Bae IH, Jeong MH, Han DK and Joung YK: Nitric oxide releasing coronary stent: A new approach using layer-by-layer coating and liposomal encapsulation. Small. 12:6012–6023. 2016.PubMed/NCBI View Article : Google Scholar
23	Zhang H, Park Y, Wu J, Chen XP, Lee S, Yang J, Dellsperger KC and Zhang C: Role of TNF-alpha in vascular dysfunction. Clin Sci (Lond). 116:219–230. 2009.PubMed/NCBI View Article : Google Scholar
24	Picchi A, Gao X, Belmadani S, Potter BJ, Focardi M, Chilian WM and Zhang C: Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr (dp) mice. Circulation. 115:245–254. 2007.PubMed/NCBI View Article : Google Scholar
25	Booth AJ, Csencsits-Smith K, Wood SC, Lu G, Lipson KE and Bishop DK: Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection. Am J Transplant. 10:220–230. 2010.PubMed/NCBI View Article : Google Scholar